A grant to investigate the link between viral infection and autoimmunity, new published findings from an OMRF scientist connecting gut health with healing ability and the announcement that an OMRF scientist has been named president of the North American Vascular Biology Organization highlight recent news fromthe Innovation District'sOklahoma Medical Research Foundation.
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 to investigate the long-term effects of viral infections on autoimmunity.
OMRF scientist Umesh Deshmukh, Ph.D., received the two-year grant to study how viral infections such as Covid-19 can influence the development of autoimmune diseases. Specifically, his lab will study the effects of a hyperactivated immune system on salivary glands that can ultimately lead to Sjgrens syndrome.
In Sjgrens syndrome, immune cells attack moisture-producing glands, leading to painful dryness anddecreased ability to produce tears or saliva. Common symptoms include severe dry eyes and mouth, fatigue, arthritis, and memory problems.
Sjgrens may affect up to 4 million Americans, according to the Sjgrens Syndrome Foundation. While its causes are not fully understood, environmental triggers, such as viral infections, are believed to contribute to the development of the disease in individuals who carry certain genetic risk factors.
We are learning more every day about the long-term side effects of SARS-CoV-2 infection, and specifically, we have learned the virus has found a niche in the salivary glands, said Deshmukh, who joined OMRF from the University of Virginia in 2013. While most people associate the virus with the lungs, we continue to see more areas of the body that are impacted in the long term. Salivary glands appear to be one of the organs at risk.
Deshmukh said they are particularly interested in seeing how the cytokine storm the virus can cause in the body activates genes and immune factors that already put certain individuals at risk for Sjgrens.
A cytokine storm happens when the body senses danger and rapidly generates a class of proteins, called cytokines, that help the immune cells to kill invading viruses or bacteria, explained Deshmukh.
When the body overproduces these cytokines, it can lead to unintended damage, he said. This response is what causes a fever when you are fighting infection. Its a good thing, but you can, unfortunately, have too much of a good thing.
To understand the effects of cytokine storms downstream regarding autoimmunity, Deshmukh and his lab will mimic viral infections in research models. They will then monitor the activation of genetic risk factors for Sjgrens and other autoimmune diseases.
We are seeing that many Covid-19 patients have an autoimmune response already initiated, he said. With diseases like Sjgrens, they can take years to emerge, so we need to hit the ground running now to get out ahead of a potential problem down the road.
The grant, R21 DE031166-01, is funded by the National Institute of Dental and Craniofacial Research, a part of the NIH.
New findings from the Oklahoma Medical Research Foundation suggest the gut microbiome may impact wound healing and cartilage regrowth.
The research from OMRF physician-scientist Matlock Jeffries, M.D., could lead to new treatment for skin wounds, severe injuries and post-traumatic arthritis, a form of osteoarthritis (OA) that develops after an injury or reconstructive surgery. Post-traumatic arthritis makes up more than 10% of OA cases and is one of the top reasons for injury-related discharge among active-duty U.S. soldiers.
Stemming from the loss of cartilage between bones and joints, OA affects an estimated 27 million Americans and is the leading cause of disability in adults in the U.S. With no way yet to regenerate cartilage, the only treatment is a joint replacement.
Knee replacements caused by OA are the number one procedure expense to Medicare each year, said Jeffries, a board-certified rheumatologist who treats patients in OMRFs Rheumatology Research Center of Excellence. But there are no drugs that stop or slow the progression of the disease.
While most OA research focuses on genetics and blood, Jeffries turned his attention to the gut microbiome. Composed of thousands of tiny organisms in our digestive tracts, scientists increasingly suspect the microbiome as a key player in numerous conditions.
Jeffries lab looked at a unique strain of mouse called a superhealer that naturally and unusually heals wounds to its ear cartilage. Ear cartilage shares many similarities to knee cartilage.
Jeffries transplanted microbiome from the healer mice into a group of mice with average healing capabilities. After the transplant, the non-healer mice demonstrated an increased ability to generate new ear cartilage, as did their offspring.
The results, published in the journal PLOS One, indicate the gut microbiome has far more influence on the immune response to injury than previously understood.
It was a completely unexpected finding, said Jeffries, noting the idea among scientists had long been that healer mice owe their abilities purely to genetics.
Jeffries lab will now study if this healing ability is related to specific microbiome organisms, how long the healing boost lasts and how it may impact outcomes for OA.
More study is needed, but potentially, said Jeffries, if an injury was caught in time, a microbiome transplant could change someones outcome.
The research was conducted in partnership with the University of Oklahoma Health Sciences Center and funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases grant No. 7K08AR070891-05, U.S. Department of Defense Congressionally Directed Medical Research Program award W81XWH-20-1-0002, and the Presbyterian Health Foundation.
Oklahoma Medical Research Foundation scientist Courtney Griffin, Ph.D., has been named president of the North American Vascular Biology Organization.
Founded in 1994, NAVBO is an international organization of scientists who study the function and diseases of blood vessels.
At OMRF, Griffin studies vessel regression. When the body grows too many or too few blood vessels in places like the eyes and kidneys, they can disrupt the normal function of the organ. Griffins team works to understand ways to control abnormal vessels. She first joined NAVBO in 2006 as a postdoctoral researcher.
Organizations like NAVBO help scientists connect with other researchers in our niche of biology, said Griffin, a scientist in the foundations Cardiovascular Biology Research Program. In science, you cant be an island and be successful.
Griffin joined OMRFs scientific staff in 2008 after completing a postdoctoral fellowship at the University of North Carolina Chapel Hill. She earned her doctorate at the University of California San Francisco following her bachelors degree at Harvard University. At OMRF, she holds the Scott Zarrow Chair in Biomedical Research.
In addition to her position at OMRF, Griffin is also the scientific director for the Oklahoma Center for Adult Stem Cell Research and an adjunct professor of cell biology at the University of Oklahoma Health Sciences Center.
As president of NAVBO, Griffin will lead the organizations global team of officers in education, outreach and advocacy efforts.
Were increasingly focused on younger students who are intrigued by vascular biology and making real progress in increasing involvement with underrepresented groups, Griffin said. Its a joy and a privilege to build a scientific family that extends around the world, and, most importantly, it empowers science.
Visit link:
- Adult Stem Cells: What They Are and What They Do - February 6th, 2025
- What Are Adult Stem Cells and Are They Right for You? - February 6th, 2025
- Stem Cell Program | Adult Stem Cells - Boston Children's Hospital - February 6th, 2025
- Different Types Of Stem Cells: Embryonic Vs. Adult ... - January 17th, 2025
- Rejuvenation of Aging Adult Stem Cells to Improve their Regenerative Potential - Frontiers - January 13th, 2025
- Hope Biosciences Research Foundation Authorized to Begin Phase II Clinical Trial in Stem Cell Therapy for Juvenile Idiopathic Arthritis - Business... - December 22nd, 2024
- What Are Stem Cells? Biomedical Beat Blog National Institute of ... - November 29th, 2024
- TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs - Veterans Affairs - November 8th, 2024
- Understanding Mature Tissue or Organ Stem Cells and Their Clinical ... - November 8th, 2024
- Biology of stem cells: an overview - PMC - PubMed Central (PMC) - October 30th, 2024
- New government tech deals boost the business of cancer detection - GOV.UK - October 11th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Yahoo News UK - October 11th, 2024
- Advances in different adult stem cell-derived exosomal non-coding RNAs for the treatment of neurological disorders: a narrative review - Frontiers - September 26th, 2024
- Breakthrough technique may help speed understanding, treatment of MD, ALS - Harvard Gazette - September 14th, 2024
- Rostock University Explores Use of Stem Cells for Meat Cultivation with Help from Innocent Meat - vegconomist - the vegan business magazine - August 12th, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Targeting the stem cell niche micro-environment as therapeutic strategies in aging - Frontiers - June 28th, 2024
- International trial introduces another curative option for sickle cell disease - EurekAlert - June 28th, 2024
- HOX genes in stem cells: Maintaining cellular identity and regulation of differentiation - Frontiers - June 28th, 2024
- Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and... - June 21st, 2024
- Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management - June 21st, 2024
- Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC. - June 21st, 2024
- Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer - June 21st, 2024
- API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines - June 21st, 2024
- Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems - June 21st, 2024
- Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform - June 21st, 2024
- Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog... - June 21st, 2024
- Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting - June 21st, 2024
- Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing - June 21st, 2024
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - June 21st, 2024
- Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran - June 21st, 2024
- Idorsia’s novel treatment for chronic insomnia wins the prestigious Prix Galien Suisse 2024 innovation award in the ‘Primary & Speciality’... - June 21st, 2024
- Radiopharm Receives Strategic Investment for up to A$18 million - June 21st, 2024
- Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee - June 21st, 2024
- Trading by management and close relations of management - June 21st, 2024
- Major shareholder announcement - June 21st, 2024
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 21st, 2024
- Nature retracts highly cited 2002 paper that claimed adult stem cells could become any type of cell - Retraction Watch - June 19th, 2024
- Shares of Biotech MicroCap Rip on Licensing Talks - The Globe and Mail - June 15th, 2024
- Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024 - May 23rd, 2024
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23rd, 2024
- Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist... - May 23rd, 2024
- Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus... - May 23rd, 2024
- Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 - May 23rd, 2024
- New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of... - May 23rd, 2024
- Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients - May 23rd, 2024
- Kane Biotech Announces First Quarter 2024 Financial Results - May 23rd, 2024
- Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast - May 23rd, 2024
- Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy - May 23rd, 2024
- Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - May 23rd, 2024
- 23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - May 23rd, 2024
- Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting - May 23rd, 2024
- Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024 - May 23rd, 2024
- Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences - May 23rd, 2024
- NANOBIOTIX to Present at the Jefferies Global Healthcare Conference - May 23rd, 2024
- Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - May 23rd, 2024
- Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual... - May 23rd, 2024
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
Recent Comments